Mankind Pharma inks licensing pact with Glenmark to co-market diabetes drug

"This is particularly important in reducing overall disease burden. Moreover, this strategic decision will not only strengthen our diabetes portfolio but also help consolidate our position as the fastest-growing player in the anti-diabetes segment," Mankind Pharma Director of Marketing Sanjay Koul said in a statement.

from Moneycontrol Business News https://ift.tt/2QfFY4P